286-300 of 447
Are We Close to Development of an Artificial Pancreas?
Diabetes DiscourseAre We Close to Development of an Artificial Pancreas?
Bruce Buckingham, MD
Steven Edelman, MD
Implications of the ACCORD, ADVANCE and VA Diabetes Trials
Diabetes DiscourseImplications of the ACCORD, ADVANCE and VA Diabetes Trials
Richard Bergenstal, MD
Steven Edelman, MD
The International Diabetes Federation's Global Campaign
Diabetes DiscourseThe International Diabetes Federation's Global Campaign
Anne-Marie Felton
Steven Edelman, MD
How Will Pharmacogenomics Play a Role in Diabetes Therapy?
Diabetes DiscourseHow Will Pharmacogenomics Play a Role in Diabetes Therapy?
Joseph Ma, PharmD
Steven Edelman, MD
DPP-4 Inhibitors: A New Class of Medications
Diabetes DiscourseDPP-4 Inhibitors: A New Class of Medications
Lisa Kroon, PharmD, CD
Steven Edelman, MD
The Importance of Diabetes Education for Patients and Providers
Diabetes DiscourseThe Importance of Diabetes Education for Patients and Providers
Sandra Bourdette
Steven Edelman, MD
- advertisement
The Importance of Immunizations for Diabetic Patients
Diabetes DiscourseThe Importance of Immunizations for Diabetic Patients
Sarah Lorentz, PharmD
Candis Morello, PharmD, CDE
Drug Delivery Systems in the Management of Diabetes
Diabetes DiscourseDrug Delivery Systems in the Management of Diabetes
Candis Morello, PharmD, CDE
Brookie Best, PharmD
New AACE Guidelines for Treating Type 2 Diabetes
Diabetes DiscourseNew AACE Guidelines for Treating Type 2 Diabetes
Daniel Einhorn, MD
Steven Edelman, MD
David Ward, MD
Steven Edelman, MD
NICE-SUGAR: Blood Glucose Levels in the ICU
Diabetes DiscourseNICE-SUGAR: Blood Glucose Levels in the ICU
Irl Hirsch, MD, MACP
Steven Edelman, MD
Thomas Moore, MD
Steven Edelman, MD
- advertisement
Weighing Therapeutic Diets for Type 2 Diabetics
Diabetes DiscourseWeighing Therapeutic Diets for Type 2 Diabetics
Steven Edelman, MD
Lorena Drago, MS, RD, CDN, CDE
Sodium-Glucose Transporters: A New Class of Diabetes Medications
Diabetes DiscourseSodium-Glucose Transporters: A New Class of Diabetes Medications
Steven Edelman, MD
Vivian Fonseca, MD, FRCP
A New Paradigm for the Treatment of Type 2 Diabetes
Diabetes DiscourseA New Paradigm for the Treatment of Type 2 Diabetes
Ralph A. DeFronzo, MD
Steven Edelman, MD
